Fluarix Immunogenicity and Safety Trial

NCT00100399 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1050

Enrollment

NIH

Sponsor class

Conditions

Influenza

Interventions

BIOLOGICAL: Fluarix

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)